companydata.dkcompanydata.dk

BIOCHEMFUSION HOLDING ApS: Financial statements 2025

CVR: 35398953

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

BIOCHEMFUSION HOLDING ApS (CVR 35398953) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 28,888 and a net result of DKK 16,110 compared with DKK 93,935 the year before. That is a decrease of 6.1% compared with the year before. The profit margin was 55.8%. Equity in the 2025 report amounted to DKK 226,586. The solvency ratio was 95.8%.

Revenue
DKK 28,888
Gross Profit
DKK 20,654
Profit/Loss
DKK 16,110
Equity
DKK 226,586
Total Assets
DKK 236,617
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202529 t.21 t.16 t.227 t.0
202431 t.24 t.94 t.261 t.0
202325 t.16 t.12 t.317 t.0
202221 t.14 t.159 t.455 t.0
202145 t.39 t.178 t.446 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOCHEMFUSION HOLDING ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

BIOCHEMFUSION HOLDING ApS: The 2024 annual report is outJun 26, 2025

BIOCHEMFUSION HOLDING ApS has published its annual report for 2024. Revenue came to DKK 30,756, and the net result was DKK 93,935.

About BIOCHEMFUSION HOLDING ApS

BIOCHEMFUSION HOLDING ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2013. The company is registered under the industry Finansielle holdingselskaber. The management consists of Jan Holst Jensen. The company is owned by JAN HOLST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 28,888 and a net result of DKK 16,110 compared with DKK 93,935 the year before. Equity in the 2025 report amounted to DKK 226,586.

Source: annual report 2025, Danish Business Authority